0.6901

5.47% -0.0399

Hyperfine Inc (HYPR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$0.73

Aprire:

$0.76

Volume 24 ore:

796.14K

Relative Volume:

0.71

Capitalizzazione di mercato:

$58.92M

Reddito:

$11.03M

Utile/perdita netta:

$-44.24M

Rapporto P/E:

-1.1131

EPS:

-0.62

Flusso di cassa netto:

$-42.61M

1 W Prestazione:

-8.84%

1M Prestazione:

-6.11%

6M Prestazione:

-29.58%

1 anno Prestazione:

-12.97%

Intervallo 1D:

$0.6534

$0.76

Intervallo di 1 settimana:

$0.6534

$0.77

Portata 52W:

$0.5837

$1.90

Hyperfine Inc Stock (HYPR) Company Profile

Nome

Hyperfine Inc

Settore

Healthcare (1152)

Industria

Medical Devices (157)

Telefono

866-796-6767

Indirizzo

351 NEW WHITFIELD STREET, GUILFORD

Dipendente

111

Cinguettio

Prossima data di guadagno

2025-03-17

Ultimi documenti SEC

HYPR's Discussions on Twitter

Confronta HYPR con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HYPR Hyperfine Inc	0.6901	58.92M	11.03M	-44.24M	-42.61M	-0.62
ABT Abbott Laboratories	132.82	223.47B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	104.93	150.72B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	378.22	139.34B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	84.85	107.15B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	75.65	44.54B	5.54B	4.18B	259.90M	7.00

Hyperfine Inc Stock (HYPR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-08-11	Downgrade	Wells Fargo	Overweight → Equal Weight
2022-05-31	Iniziato	Evercore ISI	Outperform
2022-04-14	Iniziato	Wells Fargo	Overweight

Hyperfine Inc Borsa (HYPR) Ultime notizie

Apr 29, 2025

Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025 - Business Wire

Apr 29, 2025

Apr 15, 2025

Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices - 01net

Apr 15, 2025

Hyperfine Enrolls First Patients in Portable MRI Evaluation Study - marketscreener.com

Apr 15, 2025

Hyperfine enrolls initial patients in NEURO PMR study - TipRanks

Apr 15, 2025

Revolutionary Portable MRI Secures Medicare Coverage as Major Clinical Trial Launches - Stock Titan

Apr 15, 2025

Lake Street Initiates Coverage of Hyperfine (HYPR) with Buy Recommendation - MSN

Mar 25, 2025

Mar 24, 2025

Lake Street starts Hyperfine stock with Buy, sets $1.50 target By Investing.com - Investing.com Australia

Mar 24, 2025

Lake Street starts Hyperfine stock with Buy, sets $1.50 target - Investing.com

Mar 24, 2025

Lake Street Initiates Hyperfine at Buy With $1.50 Price Target -March 24, 2025 at 08:20 am EDT - MarketScreener

Mar 24, 2025

Hyperfine initiated with a Buy at Lake Street - TipRanks

Mar 24, 2025

Mar 22, 2025

What You Can Learn From Hyperfine, Inc.'s (NASDAQ:HYPR) P/S After Its 28% Share Price Crash - Simply Wall St

Mar 22, 2025

Mar 20, 2025

Hyperfine price target lowered to $1.20 from $1.50 at B. Riley - TipRanks

Mar 20, 2025

B. Riley Trims Price Target on Hyperfine to $1.20 From $1.50, Keeps Buy Rating -March 20, 2025 at 07:57 am EDT - Marketscreener.com

Mar 20, 2025

Mar 19, 2025

Hyperfine, Inc. (NASDAQ:HYPR) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 19, 2025

Hyperfine Inc. Faces Potential Stock Price Decline Amid $150 Million Securities Sale Plan - TipRanks

Mar 19, 2025

Mar 18, 2025

Hyperfine Inc. Earnings Call: Growth Amid Challenges - TipRanks

Mar 18, 2025

Jefferies lifts Hyperfine stock price target to $1.20, keeps Hold rating By Investing.com - Investing.com South Africa

Mar 18, 2025

Jefferies lifts Hyperfine stock price target to $1.20, keeps Hold rating - Investing.com

Mar 18, 2025

HYPR Stock Jumps on NVIDIA Partnership to Advance AI Neuroimaging - Nasdaq

Mar 18, 2025

Hyperfine teams up with NVIDIA to enhance AI-powered portable MR - DOTmed HealthCare Business News

Mar 18, 2025

Hyperfine reports net loss of USD 10.39M in Q4 2024 - Medical Buyer

Mar 18, 2025